Lack of access to medicine is a major driver of drug resistance. How can pharma take action?
What leaders say
"When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that."
Co-chair and Trustee, Bill & Melinda Gates Foundation
"Africa has been overlooked when it comes to research and development of life-saving medical commodities, including COVID-19 vaccines. Free market demand and supply principles will not work on their own without an equitable access dimension. The Access to Medicine Foundation is important for accountability - tracking how and where healthcare companies live up to their commitments; as well as encouraging them to do better – in bridging gaps in equitable access to health products and achieving universal health coverage."
Dr Githinji Gitahi
Group CEO, Amref Health Africa
"I’ve been impressed by the Access to Medicine Index. It presents well-balanced stakeholder views on good practices for the pharmaceutical industry and it provides clear standards against which the performance of individual companies can be judged."
Chair of the Elders, First woman President of Ireland, former UN High Commissioner for Human Rights